Ultragenyx Pharmaceutical, Inc. (RARE)
21.46
-0.34
(-1.56%)
USD |
NASDAQ |
Mar 05, 16:00
21.47
+0.01
(+0.05%)
After-Hours: 20:00
Ultragenyx Pharmaceutical Cash from Investing (TTM) : 236.00M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Corcept Therapeutics, Inc. | 69.76M |
| Johnson & Johnson | -23.59B |
| CorMedix, Inc. | -- |
| Apellis Pharmaceuticals, Inc. | -0.313M |
| BioMarin Pharmaceutical, Inc. | -414.24M |